Skip to main content

Table 2 Final best corrected visual acuity (BCVA) compared with initial BCVA according to primary and secondary therapeutic modalities

From: Retinal fluid changes and therapeutic effects in symptomatic circumscribed choroidal hemangioma patients: a long-term follow up study

 

BCVA change

   

Treatment modality

Improved

Stable

Worsen

Total number

P + A (A + P)

5 (3 + 2) (45.45%)

1 (0 + 1) (9.09%)

5 (3 + 2) (45.45%)

11

P

4 (1 + 3) (66.67%)

2 (1 + 1) (33.33%)

 

6

A

 

1 (1 + 0) (100%)

 

1

T + A (A + T)

  

6 (6 + 0) (100%)

6

T

  

2 (2 + 0) (100%)

2

  1. Total number of patients (number of patients followed up over 48 months + number of patients followed up between 24 to 48 months)
  2. BCVA best corrected visual acuity, T transpupillary thermotherapy, P photodynamic therapy, A intravitreal bevacizumab (Avastin) injection